MedMira Company Insiders
| MIR Stock | CAD 0.09 0.01 5.56% |
MedMira employs about 5 people. The company is managed by 5 executives with a total tenure of roughly 21 years, averaging almost 4.0 years of service per executive, having 1.0 employees per reported executive. Recap of MedMira's management performance can provide insight into the venture performance.
| Hermes Chan CEO Co-Founder, CEO and President Director, CEO of Medmira Laboratories Inc and President of Medmira Laboratories Inc |
MedMira |
MedMira Management Team Effectiveness
The company has return on total asset (ROA) of (0.2645) % which means that it has lost $0.2645 on every $100 spent on assets. This is way below average. MedMira's management efficiency ratios could be used to measure how well MedMira manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.69 in 2024. Return On Capital Employed is likely to drop to 0.13 in 2024. At this time, MedMira's Non Current Assets Total are fairly stable compared to the past year. Intangibles To Total Assets is likely to climb to 0.000001 in 2024, whereas Total Assets are likely to drop slightly above 1.7 M in 2024.Common Stock Shares Outstanding is likely to climb to about 842.2 M in 2024, whereas Net Loss is likely to drop (2.2 M) in 2024.
MedMira Workforce Comparison
MedMira is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 93,968. MedMira adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.
MedMira Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. MedMira Price Series Summation is a cross summation of MedMira price series and its benchmark/peer.
MedMira Notable Stakeholders
A MedMira stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as MedMira often face trade-offs trying to please all of them. MedMira's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting MedMira's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Hermes Chan | Co-Founder, CEO and President Director, CEO of Medmira Laboratories Inc and President of Medmira Laboratories Inc | Profile | |
| Sam Ratnam | Director Affairs | Profile | |
| Stewart McKelvey | Legal Counsel | Profile | |
| Markus Meile | Chief Officer | Profile | |
| Kevin Jones | Head Marketing | Profile |
About MedMira Management Performance
The success or failure of an entity such as MedMira often depends on how effective the management is. MedMira management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of MedMira management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the MedMira management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.66) | (0.69) | |
| Return On Capital Employed | 0.14 | 0.13 | |
| Return On Assets | (0.66) | (0.69) | |
| Return On Equity | 0.20 | 0.19 |
Please note, the imprecision that can be found in MedMira's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of MedMira. Check MedMira's Beneish M Score to see the likelihood of MedMira's management manipulating its earnings.
MedMira Workforce Analysis
Traditionally, organizations such as MedMira use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare MedMira within its industry.MedMira Manpower Efficiency
Return on MedMira Manpower
| Revenue Per Employee | 86.5K | |
| Revenue Per Executive | 86.5K | |
| Net Loss Per Employee | 535.1K | |
| Net Loss Per Executive | 535.1K |
Additional Tools for MedMira Stock Analysis
When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.